Literature DB >> 17728219

Re: Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.

Nicola Fazio, Roberto Biffi, Giuseppe Curigliano, Katia Lorizzo, Maria Giulia Zampino, Filippo de Braud, Antonio Chiappa, Arnaud Roth, Aron Goldhirsch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17728219     DOI： 10.1093/jnci/djm092

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

Review 1.  Locally advanced and metastatic gastric cancer: current management and new treatment developments.

Authors:  Kathryn Field; Michael Michael; Trevor Leong
Journal:  Drugs       Date:  2008       Impact factor: 9.546

2.  Malignant gastric cancer cured by short-term chemotherapy and long-term use of combined chinese medicine: a case report.

Authors:  Hong Zhu; Tai-guo Liu; Zhang Zhang; Cheng Yi
Journal:  Chin J Integr Med       Date:  2012-09-11       Impact factor: 1.978

3.  Adjuvant Chemotherapy for Advanced Gastric Cancer in Elderly and Non-elderly Patients: Meta-Analysis of Randomized Controlled Trials.

Authors:  Seong-Hwan Chang; Soo-Nyung Kim; Hye Jung Choi; Misuk Park; Rock Bum Kim; Se-Il Go; Won Sup Lee
Journal:  Cancer Res Treat       Date:  2016-07-05       Impact factor: 4.679
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.